PatchTheCVECVE-2026-104309: IBM Langflow OSS 1.0.0 through 1.12.3 could allow a remote authenticated attacker to obtain sensitive informat
CVE-2026-104309 is a medium-severity flaw (CVSS 6.5) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
IBM Langflow OSS 1.0.0 through 1.12.3 could allow a remote authenticated attacker to obtain sensitive information due to improper limitation of a pathname to a restricted directory.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.5 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | n/a |
| CISA exploited list | No |
| Weakness | CWE-22 |
| Published | 2026-10-29 |
| Last modified | 2026-10-29 |
Last updated 2026-10-29 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Advisories and coverage
Research and news
- VulDB Recent Entries: CVE-2026-104309 | IBM Langflow OSS up to 1.12.3 path traversal 2026-10-29
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-104309?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-104309 being exploited?
CVE-2026-104309 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-104309 affect?
CVE-2026-104309 affects affected software. Severity is medium (CVSS 6.5). IBM Langflow OSS 1.0.0 through 1.12.3 could allow a remote authenticated attacker to obtain sensitive information due to improper limitation of a pathname to a restricted directory.
How urgent is CVE-2026-104309?
Priority 23/100. No elevated risk signals yet.